19th December 2018

This month:

  • Aptamer Group data on selective cell based biomarker aptamers
  • The year in review, from new product launches to company accolades
  • Interesting applications in international diagnostics and small molecule lateral flow assays

Novel Solutions – Biomarkers 

Aptamers specific to the same cell type at different stages within a disease cycle

  • No biomarker abundance restriction
  • Whole cell targets
  • Ease of labelling


Aptamers to various biomarkers can be used to differentiate between Healthy, Early Cancer and Later Stage Cancer cells and cells from a Closely Related Disease. Three different aptamer populations were used.

The Year in Review

Aptamer Group is proud of the successes we have had this year, and we look forward to new challenges in 2019:

In Review and News

UNICEF Innovation bringing lower cost aptamer diagnostics

In collaboration with Rhodes University’s Biotechnology Research Group tests for Malaria, HIV treatment efficiency, and pregnancy are being developed

Cortisol aptamer in lateral flow assay

Detection of the key hormone cortisol using Au nanoparticles functionalised with cortisol-selective aptamers as a convenient and low cost POC sweat-based sensor for cortisol and other stress biomarkers.

Coming Soon

Watch for our international announcement on therapeutic development with a major pharmaceutical strategic partner and our new catalogue aptamer data sheets.
We hope you have enjoyed the October new update- if you would like information on any of the topics we have covered or anything else, please do not hesitate to get in touch or use the form below.